Abstract
Central nervous system metastasis in non-small cell lung cancer remains a therapeutic challenge and confers a poor prognosis. Here we describe a patient with lung adenocarcinoma, parenchymal brain metastases, and leptomeningeal carcinomatosis who demonstrated a sustained response to programmed death 1 inhibition combined with stereotactic radiosurgery.
Original language | English (US) |
---|---|
Pages (from-to) | e159-e161 |
Journal | Oncologist |
Volume | 23 |
Issue number | 12 |
DOIs | |
State | Published - Dec 2018 |
ASJC Scopus subject areas
- Oncology
- Cancer Research